Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8851-8900 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05441488
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
PHASE3
Active, not recruiting
800 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
37 locations
NCT05221645
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2
Active, not recruiting
65 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT05186753
(Summit) a Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients with Indolent or Smoldering Systemic Mastocytosis
PHASE2
Active, not recruiting
207 participants
Started: Jun 27, 2022 · Completed: Apr 30, 2030
8 conditions
1 sponsor
69 locations
NCT05433077
Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment
N/A
Active, not recruiting
400 participants
Started: Jun 27, 2022 · Completed: Dec 30, 2025
3 conditions
2 sponsors
15 locations
NCT05382442
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
254 participants
Started: Jun 27, 2022 · Completed: Aug 12, 2028
1 condition
2 sponsors
4 locations
NCT05663970
Virtual Group Social ABCs - Multi-site Randomized Controlled Trial
NA
Active, not recruiting
120 participants
Started: Jun 27, 2022 · Completed: Mar 30, 2026
5 conditions
6 sponsors
1 location
NCT05403541
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
PHASE3
Active, not recruiting
240 participants
Started: Jun 27, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
105 locations
NCT05434962
The Left Bundle Cardiac Resynchronization Therapy Trial
NA
Active, not recruiting
176 participants
Started: Jun 27, 2022 · Completed: Aug 31, 2025
3 conditions
2 sponsors
10 locations
NCT04919434
Intervention to Reduce Exposure to Environmental COntaminant (IRECO)
NA
Active, not recruiting
107 participants
Started: Jun 26, 2022 · Completed: Jun 25, 2027
1 condition
1 sponsor
1 location
NCT05488847
Opioid-Free Pain Protocol After Shoulder Arthroplasty
PHASE4
Active, not recruiting
80 participants
Started: Jun 25, 2022 · Completed: Sep 1, 2026
2 conditions
1 sponsor
1 location
NCT05374473
An Online Lifestyle Modification Course for People With Multiple Sclerosis
NA
Active, not recruiting
945 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05759624
Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)
N/A
Active, not recruiting
10 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05174507
Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes
PHASE2
Active, not recruiting
26 participants
Started: Jun 24, 2022 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT06247280
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
N/A
Active, not recruiting
2,001 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
39 locations
NCT04613414
Evaluation of an Early Management Strategy for Obstructive Sleep Apnea
NA
Active, not recruiting
170 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04630730
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC
PHASE2
Active, not recruiting
46 participants
Started: Jun 24, 2022 · Completed: Jun 30, 2030
1 condition
1 sponsor
10 locations
NCT05388929
Methocarbamol in Ventral and Inguinal HR
PHASE4
Active, not recruiting
164 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05405166
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
PHASE3
Active, not recruiting
531 participants
Started: Jun 23, 2022 · Completed: Mar 23, 2027
1 condition
1 sponsor
146 locations
NCT05023993
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
NA
Active, not recruiting
20 participants
Started: Jun 23, 2022 · Completed: Oct 7, 2025
3 conditions
2 sponsors
1 location
NCT06267742
Clinical Trial to Evaluate MDW for Early Detection of Sepsis
N/A
Active, not recruiting
2,200 participants
Started: Jun 23, 2022 · Completed: Sep 30, 2026
1 condition
4 sponsors
3 locations
NCT05464433
Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
46 participants
Started: Jun 23, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
6 locations
NCT05403450
A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)
PHASE1/PHASE2
Active, not recruiting
33 participants
Started: Jun 23, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
46 locations
NCT05542511
Host Blood RNA Signatures for Diagnosis of TB
N/A
Active, not recruiting
1,458 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04975997
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE3
Active, not recruiting
864 participants
Started: Jun 23, 2022 · Completed: Jun 25, 2032
1 condition
1 sponsor
259 locations
NCT04530123
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
PHASE2
Active, not recruiting
102 participants
Started: Jun 23, 2022 · Completed: Jan 19, 2026
1 condition
1 sponsor
48 locations
NCT05257824
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
PHASE4
Active, not recruiting
528 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2026
2 conditions
9 sponsors
8 locations
NCT05592639
VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer
NA
Active, not recruiting
50 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2025
3 conditions
4 sponsors
1 location
NCT05379166
Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome
PHASE2
Active, not recruiting
32 participants
Started: Jun 23, 2022 · Completed: Oct 15, 2025
2 conditions
1 sponsor
3 locations
NCT05126355
Effectiveness of the On the Move Group Exercise Program to Improve Mobility in Community-dwelling Older Adults
NA
Active, not recruiting
502 participants
Started: Jun 23, 2022 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT06956157
NAC for Treatment-Resistant OCD and Other Related Disorders
PHASE4
Active, not recruiting
90 participants
Started: Jun 22, 2022 · Completed: Nov 13, 2025
1 condition
1 sponsor
1 location
NCT05510193
Redesign, Implementation and Evaluation of the Effectiveness of the Aktio Myoelectric Prosthesis
NA
Active, not recruiting
10 participants
Started: Jun 22, 2022 · Completed: Dec 27, 2023
3 conditions
2 sponsors
2 locations
NCT05459415
Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC
NA
Active, not recruiting
54 participants
Started: Jun 22, 2022 · Completed: Jun 21, 2027
3 conditions
1 sponsor
1 location
NCT05251675
Effect of Physician Peer Coaching on Burnout in Hospital-Based Physicians: A Pilot Randomized Clinical Trial
NA
Active, not recruiting
50 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT06220890
Clinical Performance of Two Different Bevel Preparations in Class IV Lesions Using Nanofilled Composite
NA
Active, not recruiting
100 participants
Started: Jun 22, 2022 · Completed: Mar 31, 2024
1 condition
1 sponsor
1 location
NCT05126758
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
PHASE3
Active, not recruiting
104 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2027
8 conditions
1 sponsor
20 locations
NCT05147506
Digital Therapeutic for Depression After Head Injury in Current and Former US Military Personnel
NA
Active, not recruiting
113 participants
Started: Jun 22, 2022 · Completed: Jan 1, 2025
2 conditions
1 sponsor
1 location
NCT05138991
Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors
NA
Active, not recruiting
149 participants
Started: Jun 22, 2022 · Completed: Jul 16, 2026
2 conditions
2 sponsors
1 location
NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
PHASE1/PHASE2
Active, not recruiting
6 participants
Started: Jun 21, 2022 · Completed: Oct 30, 2028
17 conditions
1 sponsor
7 locations
NCT04926285
Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)
PHASE1
Active, not recruiting
6 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05235516
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
PHASE3
Active, not recruiting
636 participants
Started: Jun 21, 2022 · Completed: May 31, 2029
1 condition
1 sponsor
9 locations
NCT04924803
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
NA
Active, not recruiting
545 participants
Started: Jun 21, 2022 · Completed: Feb 27, 2026
1 condition
3 sponsors
1 location
NCT05008718
Silver Diamine Fluoride: A Randomized Controlled Trial on Its Effectiveness As A Caries Arresting Agent
NA
Active, not recruiting
122 participants
Started: Jun 21, 2022 · Completed: Feb 29, 2024
2 conditions
1 sponsor
1 location
NCT05358938
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
EARLY_PHASE1
Active, not recruiting
22 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05340673
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
PHASE1
Active, not recruiting
208 participants
Started: Jun 21, 2022 · Completed: Dec 21, 2025
2 conditions
2 sponsors
1 location
NCT04788043
Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma
PHASE2
Active, not recruiting
8 participants
Started: Jun 21, 2022 · Completed: Oct 31, 2027
4 conditions
2 sponsors
2 locations
NCT05316701
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
PHASE3
Active, not recruiting
187 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2026
7 conditions
1 sponsor
19 locations
NCT05433389
App Delivered Brief Mindfulness Intervention for Surgical Patients
NA
Active, not recruiting
823 participants
Started: Jun 21, 2022 · Completed: Nov 1, 2025
3 conditions
1 sponsor
1 location
NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
N/A
Active, not recruiting
2,845 participants
Started: Jun 20, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
N/A
Active, not recruiting
4,000 participants
Started: Jun 20, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05306574
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)
PHASE3
Active, not recruiting
350 participants
Started: Jun 20, 2022 · Completed: Mar 2, 2027
1 condition
1 sponsor
78 locations
Previous
1
More pages
175
176
177
178
179
180
181
More pages
431
Next